Previous Article | Next Article ![]()
Applied and Environmental Microbiology, January 2003, p. 233-240, Vol. 69, No. 1
0099-2240/03/$08.00+0 DOI: 10.1128/AEM.69.1.233-240.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, 2780-156 Oeiras, Portugal,1 Department of Biology, University of Konstanz, 78457 Konstanz, Germany2
Received 23 July 2002/ Accepted 22 October 2002
|
|
|---|
-D-mannosyl-D-glycerate from externally added labeled mannose without the loss of specific isotopic enrichment. The strain carries a deletion in the manA gene, encoding phosphomannose isomerase. This deletion prevents the formation of fructose-6-phosphate from mannose-6-phosphate after the uptake of mannose from the medium by mannose-specific enzyme II of the phosphotransferase system (PtsM). The strain also has a deletion of the cps gene cluster that prevents the synthesis of colanic acid, a mannose-containing polymer. Plasmid-encoded phosphomannomutase (cpsG) and mannose-1-phosphate guanylyltransferase (cpsB) ensure the formation of GDP-mannose. A second plasmid harbors msg, a gene from Rhodothermus marinus that encodes mannosylglycerate synthase, which catalyzes the formation of 2-O-
-D-mannosyl-D-glycerate from GDP-mannose and endogenous glycerate. The rate-limiting step in 2-O-
-D-mannosyl-D-glycerate formation is the transfer of GDP-mannose to glycerate. 2-O-
-D-mannosyl-D-glycerate can be released from cells by treatment with cold-water shock. The final product is formed in a yield exceeding 50% the initial quantity of labeled mannose, including loss during preparation and paper chromatography. |
|
|---|
-D-Mannosyl-D-glycerate (MG) is one of the most widespread compatible solutes of thermophilic or hyperthermophilic bacteria and archaea (21). This compound has otherwise been encountered only in the red algae of the order Ceramiales (4). The highly preferential distribution of MG among organisms requiring high temperatures for growth led to the hypothesis that it could play a role in the thermoprotection of cell components in vivo. This speculation still lacks experimental proof, but at least in vitro, MG has been shown to be highly efficient in the protection of enzymes against thermal inactivation (3, 19). In order to study the metabolic fate of MG and the mechanisms underlying its stabilizing effect on proteins, it is desirable for this compound to be available in a labeled form with a high level of specific isotopic enrichment (14C, 13C); at present, such a compound is not commercially available.
The biosynthesis of MG has been characterized in detail for the thermophilic bacterium Rhodothermus marinus (12) and for the hyperthermophilic archaeon Pyrococcus horikoshii (7). The known pathways involve the transfer of
-mannosyl residues from GDP-mannose to either D-glycerate, forming MG, or D-3-phosphoglycerate, followed by hydrolysis of mannosyl-3-phosphoglycerate to MG (7, 12). Most organisms in which the synthesis of MG has been observed are not accessible for easy genetic manipulation (21). Thus, the conversion of a simple radioactive sugar for the formation of MG is plagued by its fast metabolism after entering the producing organism. This situation is due to the common separation of catabolic and anabolic pathways seen for sugar-type compatible solutes. The strict separation of trehalose metabolism and its internal synthesis is a typical example of this phenomenon (10). Therefore, we thought of using a genetically altered Escherichia coli strain to synthesize MG from external mannose. E. coli does produce GDP-mannose, mainly for the synthesis of colanic acid via GDP-fucose (2, 9). The cpsB gene, encoding the enzyme for GDP-mannose synthesis (mannose-1-phosphate guanylyltransferase), and the cpsG gene, encoding phosphomannomutase, form an operon that is part of the cps gene cluster necessary for the synthesis of colanic acid (25).
By constructing an E. coli strain that is unable to metabolize mannose and by using plasmid-encoded enzymes, we were able to channel the uptake of mannose preferentially into conversion to GDP-mannose and MG.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains and plasmids used
|
When needed, amino acids were added to the minimal medium at the following concentrations: histidine, 0.15 g/liter; isoleucine, 0.21 g/liter; leucine, 0.46 g/liter; and valine, 0.32 g/liter. The vitamins pyrodoxine and B12 were used at 2.5 and 1 mg/liter, respectively.
Genetic construction of the producer strain.
P1vir transductions were performed as described by Miller (15); P1vir was from a laboratory stock. In order to use arabinose-induced promoters, it was necessary to introduce an araABC-leu deletion. The nearby kefE::Tn10 pdx marker was introduced into strain MC1061, carrying
(araABC-leu). By selecting for Tetr and screening for loss of growth on arabinose and prototrophy for pyrodoxine, we obtained strain MS0501. A P1 lysate of this strain was used to transfer
(araABC-leu) into strain SG20273, harboring a cps-his deletion. The resulting strain, MS1501, is still kefE::Tn10
(araABC-leu)
(cps-his).
cps was necessary to prevent the usage of GDP-mannose mainly for colanic acid synthesis. To remove kefE::Tn10, we used a lysate of MC1061 to render MS1501 pdx+ Tets, yielding strain MS1601. In order to transfer the ptsG mutation of UE26 into MS1601, we introduced zce-726::Tn10, located at 24.25 min on the E. coli chromosome (24), into UE26 and obtained strain MS2601. A lysate of MS2601 allowed us to transfer the ptsG mutation into MS1601 and, by selecting for Tetr and screening for reduced growth on glucose, we obtained strain MS3601. The
(dgsA [mlc]-manA) deletion of strain PK2242 was introduced into MS3601 with the help of the nearby marker nth::kan. By selecting for kanamycin resistance and screening for loss of growth on mannose, we obtained strain MS4601. This producer strain is characterized by sensitivity to mannose and by slow growth on glucose. Additionally, MS4601 can be used to express arabinose-inducible genes. It has lost any sensitivity to arabinose. The final strain has the tendency to form mutations on Luria-Bertani plates, presumably because mannose is present in Luria-Bertani medium, and mutations arise that render the strain mannose negative. In the presence of 0.2% glucose or on glucose minimal medium plates, the strain is stable.
Preparation of plasmids and transformations were carried out according to standard protocols (20).
Construction of plasmids.
Two primers (5'-GTCTAGAATGGCGCAGTCGAAACTC-3' and 5'-CGCCTGCAGTTACTCGTTCAGCAACGTC-3') containing the additional XbaI and PstI recognition sequences (underlined) were used to amplify the genes cpsG (encoding phosphomannomutase) and cpsB (encoding mannose-1-phosphate guanylyltransferase) from genomic DNA of E. coli MC4100. The PCR product was digested with the corresponding restriction enzymes and ligated into pTrc99B. The resulting plasmid was named pMS104 and carries cpsG-cpsB under the control of an isopropyl-ß-D-thiogalactopyranoside (IPTG)-inducible promoter. To construct a vector carrying the mgs gene, encoding MG synthase of R. marinus, and compatible for use in combination with pMS104, we exchanged the antibiotic resistance of pMG37. The sequence coding for chloramphenicol resistance, which was used for the exchange, was obtained from digestion of pACYC184. In this way, we obtained plasmid pMS101. The producer strain was maintained free of plasmids. Only freshly transformed strains were used for MG production.
[14C]MG and [14C]GDP-mannose production from [14C]mannose in whole cells.
For evaluating the products formed in MS4601 cells, washed cultures of cells with and without plasmids were exposed to external mannose (see Fig. 2). Transformed cells were grown in NZA medium with 0.2% glucose to an optical density at 600 nm (OD600) of 0.5. After induction with 1 mM IPTG and further growth for 6 h, cells were harvested and resuspended in MMA (without a carbon source) to a final OD600 of 1.0. To 6 ml of this cell suspension, [14C]mannose was added to a final concentration of 0.078 µM (0.14 µCi). After different time intervals, 1-ml samples were withdrawn and centrifuged, and the pellet was resuspended in 5 µl of 12% trichloroacetic acid (TCA). The mixture was kept on ice for 10 min and centrifuged, and the supernatant was applied to a TLC plate (Silica 60; Merck). Chromatograms were run with a solvent system composed of n-propanol and 25% ammonia (1:1, vol/vol). Authentic standards for mannose, mannose-1-phosphate, mannose-6-phosphate, GDP-mannose, and MG were used for comparison. After being dried, the TLC plate was autoradiographed for 3 days. Nonlabeled standards were visualized by spraying with
-naphthol- sulfuric acid solution followed by charring at 120°C (11).
![]() View larger version (59K): [in a new window] |
FIG. 2. Formation of 14C-labeled products from external [14C]mannose. (A) MS4601. (B) MS4601/pMS104. (C) MS4601/pMS104/pMS101. In each experiment, 6 ml of cells (OD600, 2) was incubated with 0.14 µCi of [14C]mannose, equivalent to 0.078 nmol. The supernatants of TCA-treated cells were analyzed by TLC and autoradiographed. Lanes contain samples from the following time points: 1, 10 s; 2, 1 min; 3, 5 min; 4, 15 min; and 5, 30 min. The positions of the known products are indicated. When GDP-mannose (GDP-man) was present (panels B and C), an additional product was formed and ran ahead of MG; it was tentatively assigned as fucose.
|
![]() View larger version (68K): [in a new window] |
FIG. 3. Time-dependent formation of [14C]MG from external [14C]mannose in MS4601/pMS104/pMS101. In each experiment, 6 ml of cells (OD600, 1) was incubated with 0.14 µCi of [14C]mannose. Unlabeled mannose was added at various concentrations: A, 0.078 µM (no addition of unlabeled mannose); B, 0.1 µM; C, 0.5 µM; D, 1 µM; E, 5 µM; and F, 10 µM. The supernatants of TCA-treated cells (5 µl) were analyzed by TLC and autoradiographed. Lanes contain samples from the following time points: 1, 10 s; 2, 5 min; 3, 20 min; 4, 40 min; and 5, 90 min.
|
The final product was checked by TLC along with authentic unlabeled MG.
Transport assays.
MS4601, MS4601/pMS104, and MS4601/pMS104/pMS101 cells were grown in NZA medium with 0.2% glucose; 1 mM IPTG was added for induction. Cells were harvested (8,000 x g, 7 min, 10°C), washed twice with MMA, and resuspended in MMA without a carbon source. To measure the transport of mannose, we used a cell suspension with an OD600 of 1.5 to 2.0. To 6 ml of culture, prewarmed for 2 min at 40°C, 0.3 µM [14C]mannose was added. For higher concentrations of mannose, cold substrate was premixed with radioactive substrate (we always used the same concentration of labeled material). At each time point, 1 ml of culture was filtered, and the rate of uptake of mannose was determined by filtration. [14C]Mannose was purchased from Amersham Pharmacia. It had a specific radioactivity of 296 mCi/mmol.
|
|
|---|
![]() View larger version (14K): [in a new window] |
FIG. 1. Strategy for construction of producer strain MS4601. Note that mannose cannot be metabolized and is converted to MG without the input of unlabeled cellular precursors. PtsG and PtsM are transport systems for glucose and mannose, respectively. P, phosphate.
|
Production of mannose-6-phosphate, GDP-mannose, and MG.
Cells of strain MS4601 without plasmids, harboring plasmid pMS104, or harboring plasmids pMS104 and pMS101 were exposed to labeled mannose, and the internally formed products were analyzed by TLC (Fig. 2). In the absence of any plasmid, one major spot, representing mannose-6-phosphate, was seen (Fig. 2A). In the presence of plasmid pMS104 (Fig. 2B), the additional production of GDP-mannose was observed. Since mannose-6-phosphate and mannose-1-phosphate run at the same positions in the solvent system used, the ratio of these two compounds could not be determined. In the presence of both plasmids (Fig. 2C), an additional compound representing MG was detected. A weakly labeled spot running above MG was also observed and tentatively assigned as fucose. The strain synthesizing GDP-mannose but not MG synthesized small amounts of a product running below mannose-1-phosphate or mannose-6-phosphate. This material was present in smaller amounts when MG synthase was present. Therefore, we believe it to be a mannose product transferred to an unknown acceptor. Occasionally, we observed a spot running at the same position as free mannose. This spot was more prominent in strains lacking MG synthesis, indicating that GDP-mannose in the absence of a suitable acceptor might be slowly degraded internally to mannose.
Estimation of the rates of synthesis of MG and GDP-mannose.
Cells containing both plasmids were exposed to 0.078 µM [14C]mannose in the presence of increasing amounts (up to 10 µM) of unlabeled mannose. The time-dependent formation of labeled products was analyzed by TLC (Fig. 3). Under the chosen conditions, external mannose was taken up by the cells in all experiments within 2 min. At a high specific radioactivity and a low external concentration of mannose (0.078 µM), the synthesis of MG was immediate. Considering the internal cell volume of the culture, the initial internal concentration of the precursors under these conditions was estimated to be about 80 µM. With decreasing specific activity and increasing amounts of external mannose, the formation of labeled MG seemingly declined, while free pools of mannose-6-phosphate or mannose-1-phosphate and GDP-mannose increased. We used an experiment in which cells were exposed to 10 µM mannose (Fig. 3F) to estimate the in vivo rate of production of MG. Under these conditions, the internal concentration of GDP-mannose was on the order of 10 mM. The rate of MG formation was calculated by measuring the radioactivities of the different spots with phosphorimaging, taking into account the dilution of the radioactivity. We found that the synthesis of MG (0.08 nmol/min/109 cells) was slow in comparison to the formation of GDP-mannose (0.25 nmol/min/109 cells). This has to be compared to the rate of mannose uptake at 10 µM mannose, which is 2.9 nmol/min/109 cells (see below).
As an alternative method for extracting the labeled compounds, we treated the harvested cells with ice-cold water after exposing them to different external concentrations of [14C]mannose for different times. The corresponding supernatants were lyophilized and analyzed by TLC (Fig. 4). Again, it became apparent that the in vivo synthesis of MG was limited by the conversion of GDP-mannose to MG. The cold-water shock released, without preference for any of the labeled compounds, at least 95% of the accumulated radioactivity, as demonstrated by TLC analysis of TCA-treated pellets (data not shown). As shown in Fig. 4, when a higher initial concentration of MG (20 µM) was used, the percentage of radioactivity declined over time. We believe this to be due to the release of labeled MG prior to the cold-water shock treatment. Indeed, small amounts of labeled MG (only MG, no other labeled compound) could be detected in the medium supernatant prior to the shock treatment (data not shown).
![]() View larger version (61K): [in a new window] |
FIG. 4. Release of labeled compounds after treatment with ice-cold water. MS4601/pMS101/pMS104 was grown in NZA medium with 0.2% glucose. Washed cultures were incubated with 1, 5, and 20 µM [14C]mannose containing the same total radioactivity (0.14 µCi). At the indicated times, 1-ml samples were withdrawn, harvested, and treated with ice-cold water. The supernatants were analyzed by TLC and autoradiographed. Time of harvest indicates the time of centrifugation; the radioactivity percentage indicates the amount of radioactivity with respect to the initial radioactivity present within the cells at the time indicated. Extraction with cold water released almost 100% of the radioactivity accumulated at the time. The radioactivity remaining in the medium was not analyzed. P, phosphate.
|
Preparative synthesis of [14C]MG.
For the preparation of radioactively labeled MG, undiluted [14C]mannose was used, and the final product was separated by paper chromatography of material released from harvested cells by ice-cold water treatment. The yield with respect to the input of mannose was 56%. This value includes the loss of material during the different procedures (cold shock, concentration, chromatography, and elution from paper). According to the metabolic scheme (Fig. 1), no dilution of the specific radioactivity should occur. The isolated product was checked by TLC, and one major spot was detected. The radioactive material behaved like authentic nonlabeled MG (Fig. 5).
![]() View larger version (101K): [in a new window] |
FIG. 5. Confirmation of authenticity of radiolabeled MG. (A) Radiolabeled MG isolated from preparative synthesis and paper chromatography. (B) Paper chromatogram of MG and mannose. Lane 1, radioactive material obtained by the paper chromatography shown in panel B; lane 4, authentic nonlabeled MG; lanes 2 and 3, mixtures of labeled product and nonlabeled authentic MG. Lanes 1 and 2 show samples subjected to TLC and autoradiography; lanes 3 and 4 show samples stained with -naphthol- sulfuric acid solution and charred at 120°C. Note that lanes 2 and 3 represent the same spot that has been autoradiographed (lane 2) and charred (lane 3). The small spot ahead of MG has not been identified but could be D-fucose.
|
Transport assays.
The uptake of radioactive mannose was analyzed with MS4601, MS4601/pMS104, and MS4601/pMS104/pMS101 cells at different external mannose concentrations. Initial rates were determined and plotted against mannose concentrations. Figure 6 shows that uptake occurred with an apparent Km of 5.6 µM and a Vmax of 5.8 nmol/min/109 cells for the strain with two plasmids. The Km and Vmax values obtained for MS4601 with pMS104 alone or with no plasmid were identical within the limit of experimental error.
![]() View larger version (10K): [in a new window] |
FIG. 6. Transport of [14C]mannose. Washed cultures of strain MS4601 harboring pMS101 and pMS104 were tested in MMA without a carbon source. The assay was done at 42°C, and [14C]mannose was added at increasing concentrations (0.05 to 40 µM). Initial rates of uptake were determined and are plotted against substrate concentration. A Km of 5.6 µM and a Vmax of 5.8 nmol/min/109 cells were determined for the strain containing the two plasmids. Strains containing only pMS101 or no plasmid showed transport activities that were identical within the limit of experimental error (not shown).
|
|
|
|---|
The overall synthesis of MG appears to be limited mainly by the transfer of
-mannosyl residues from GDP-mannose to D-glycerate. The external addition of glycerol or glycerate did not increase the yield of MG (data not shown). Thus, the internal pool of glycerate cannot be the limiting factor in MG synthesis. Neither does mannose transport appear to be limiting in the producer strain, since the mannose uptake rate was approximately 70-fold higher than the rate of MG synthesis (5.8 compared to 0.08 nmol/min/109 cells). Surprisingly, the rate of formation of GDP-mannose also was not very high despite the fact that GDP-mannose pyrophosphorylase was plasmid encoded and should have been present in large amounts. This result suggests that the formation of GTP is the next rate-limiting step after MG synthase activity is increased.
Engineered strain MS4601 is sensitive to mannose, most likely due to the accumulation of intermediates. By using this sensitivity as a selection marker, conceivably at increasing salt concentrations, it might be possible to isolate mutations leading to an overall higher rate of MG synthesis and thus increase the concentration of internal MG as an effective protective osmolyte. Glucose used as a carbon source in the presence of mannose would ensure the maintenance of PtsM as a port of entrance for glucose and mannose, avoiding an undesired mode of resistance (loss of mannose uptake). If successful, the strain might also be used for the synthesis of large amounts of unlabeled MG from mannose; in addition, with a small alteration in the strain (deletion of phosphofructokinase and introduction of wild-type mannose-6-phosphate isomerase), glucose might be used as an inexpensive starting material for the synthesis of MG.
Although limited by several shortcomings (presence of two plasmids and low rate of MG synthesis), the producer strain allows the high-yield formation of labeled MG from labeled mannose without the loss of specific radioactivity. Labeled MG can now be used for studying the properties of this novel osmolyte. After exposure to limited amounts of mannose, uptake of mannose into cells, and the formation of internal MG, we did detect small quantities of labeled MG in the medium without other labeled compounds. Thus, this material must have leaked from the cells in a selective process. This observation suggests the possibility of optimizing the production and selective release of MG after cloning of the responsible exit carrier for MG.
This work was supported by the European Community 5th Framework Program (project QLK3-CT-2000-00640) and by POCTI and FEDER (project 3571/BIO/2000). M.-M.S. was the recipient of PhD grant BD71180/2000, FCT, Portugal. Support from the Fonds der Chemischen Industrie is also acknowledged.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»